Similarly, stromal PGE2-EP3 signaling is required for VEGF-A expression and tumor-associated angiogenesis in lung carcinoma whereas PGE2-EP2 signalling enhanced motility and survival of blood vascular endothelial cells, as well as angiogenesis, in a model of breast cancer [121, 130]. Here, PTGER3 is linked to neoplasm.